Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment

Background: In patients with differentiated thyroid cancer (DTC) and raising serum thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an empiric 131I therapy may be considered. However, outcome data after empiric therapy in did not show a clear evidence of improved...

Full description

Bibliographic Details
Main Authors: Michele Klain, Leonardo Pace, Emilia Zampella, Teresa Mannarino, Simona Limone, Emanuela Mazziotti, Giovanni De Simini, Alberto Cuocolo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Endocrinology
Subjects:
differentiated thyroid carcinoma
131I empiric therapy
prognosis
thyroglobulin
whole body scan
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00146/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00146/full

Similar Items